Atlas Trials

Acetyl-L-Carnitine Supplementation During HCV Therapy With Peg IFN-α2b Plus Ribavirin: Effect on Work Performance.

Clinical trial NCT01909557 · COMPLETED

Trial details

NCT number
NCT01909557
Sponsor
University of Catania
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Quality of LifeDaily ActivityFatigue
Start date
2010-01-01
Primary completion
2011-12-01
Enrollment
62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.